GNI Group Ltd banner

Intrinsic Value

Is GNI Group Ltd undervalued or overvalued?

See the intrinsic value estimate for GNI Group Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

GNI Group Ltd Intrinsic Value
LOCKED
Unlock
Today vs. history

GNI Group Ltd looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with GNI Group Ltd’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor GNI Group Ltd
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price ¥3 215
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to GNI Group Ltd

Fundamental Analysis

What GNI Group Does

Biotechnology Health Care

GNI Group Ltd is a Japanese biopharmaceutical company that discovers and develops new medicines, with a focus on hard-to-treat diseases such as fibrosis. Its work is centered on drug candidates rather than large-scale drug manufacturing, so the company acts mainly as a developer of potential therapies that can move through testing and, if successful, be licensed or commercialized with partners.

Headquarters
Japan JP
Employees
990
IPO date
Aug 31, 2007
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
GNI Group Ltd

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

What is the Intrinsic Value of one GNI Group Ltd stock?

The intrinsic value for GNI Group Ltd (2160) under the Base Case is hidden JPY.

Is GNI Group Ltd stock undervalued or overvalued?

Compared with the current market price of 3 215 JPY, the stock appears hidden.

Back to Top